Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor
Authors:
- H. WongHWH. Wong
- J.C. MarstersJMJ.C. Marsters
- Y. ShinY. Shin
- 21 October 2009
- journal article
- Published by Taylor & Francis in Xenobiotica
- Vol. 39 (11) , 850-861
Abstract
(2009). Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor. Xenobiotica: Vol. 39, No. 11, pp. 850-861.Keywords
This publication has 17 references indexed in Scilit:
- Semisynthetic Cyclopamine Analogues as Potent and Orally Bioavailable Hedgehog Pathway AntagonistsJournal of Medicinal Chemistry, 2008
- An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancerMolecular Cancer Therapeutics, 2008
- Dose- and Route-Dependent Teratogenicity, Toxicity, and Pharmacokinetic Profiles of the Hedgehog Signaling Antagonist Cyclopamine in the MouseToxicological Sciences, 2008
- Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancerBioorganic & Medicinal Chemistry, 2008
- Targeting the Hedgehog pathway in cancerNature Reviews Drug Discovery, 2006
- Targeting Medulloblastoma: Small-Molecule Inhibitors of the Sonic Hedgehog Pathway as Potential Cancer TherapeuticsCancer Research, 2005
- Hedgehog signalling in prostate regeneration, neoplasia and metastasisNature, 2004
- Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumoursNature, 2003
- Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancerNature, 2003
- Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative ParadigmDrug Metabolism Reviews, 1984